Richard A. Miller MD

Filings by Richard A. Miller MD span 2 companies, the busiest being Corvus Pharmaceuticals, Inc. and Pharmacyclics Inc. In total, 48 filings cover trades dated from 21 August 2007 to 7 May 2025.

On the market, this insider has only ever bought: 42 purchases, €3.0M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.

In size, the median ticket on the buying side is €19k. Of 40 purchases, 15 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 40 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 43% of cases, with a median move of -3.6%. Past outcomes like these are no guarantee of what comes next.

The latest filing, published on 9 May 2025, reports an option exercise of €1.7M in Corvus Pharmaceuticals, Inc. The most recent open-market purchase was published on 7 May 2024, 900 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.